{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:18:33Z","timestamp":1790399913598,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.tips.2012.03.003","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T12:15:29Z","timestamp":1337343329000},"page":"323-330","source":"Crossref","is-referenced-by-count":149,"title":["Pregnane X receptor as a target for treatment of inflammatory bowel disorders"],"prefix":"10.1016","volume":"33","author":[{"given":"Jie","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatrik M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2012.03.003_bib0005","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/ibd.21585","article-title":"Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease","volume":"17","author":"Long","year":"2011","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.tips.2012.03.003_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MOG.0b013e3283412e87","article-title":"Inflammatory bowel disease and colitis: new concepts from the bench and the clinic","volume":"27","author":"Vermeire","year":"2011","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.tips.2012.03.003_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-642-03503-6_6","article-title":"Inflammatory bowel disease and colon cancer","volume":"185","author":"Jawad","year":"2011","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.tips.2012.03.003_bib0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2012.03.003_bib0025","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/MOG.0b013e32833f126d","article-title":"Innate and adaptive immune connections in inflammatory bowel diseases","volume":"26","author":"Rakoff-Nahoum","year":"2010","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.tips.2012.03.003_bib0030","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","article-title":"Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci","volume":"42","author":"Franke","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2012.03.003_bib0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tips.2012.03.003_bib0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.764","article-title":"Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47","volume":"43","author":"Anderson","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2012.03.003_bib0045","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ni.1782","article-title":"Activation of innate immune antiviral responses by Nod2","volume":"10","author":"Sabbah","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tips.2012.03.003_bib0050","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ng2032","article-title":"Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis","volume":"39","author":"Rioux","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2012.03.003_bib0055","doi-asserted-by":"crossref","first-page":"e1001195","DOI":"10.1371\/journal.pgen.1001195","article-title":"Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease","volume":"6","author":"Danoy","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tips.2012.03.003_bib0060","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng.221","article-title":"Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility","volume":"40","author":"Franke","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2012.03.003_bib0065","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/ng.483","article-title":"Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2012.03.003_bib0070","doi-asserted-by":"crossref","first-page":"e7609","DOI":"10.1371\/journal.pone.0007609","article-title":"Loss of hepatocyte-nuclear-factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice","volume":"4","author":"Darsigny","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2012.03.003_bib0075","doi-asserted-by":"crossref","first-page":"e23745","DOI":"10.1371\/journal.pone.0023745","article-title":"Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease","volume":"6","author":"Nijmeijer","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2012.03.003_bib0080","doi-asserted-by":"crossref","first-page":"40409","DOI":"10.1074\/jbc.R110.182451","article-title":"Endogenous ligands for nuclear receptors: digging deeper","volume":"285","author":"Schupp","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2012.03.003_bib0085","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.intimp.2010.07.007","article-title":"PPARalpha contributes to colonic protection in mice with DSS-induced colitis","volume":"10","author":"Azuma","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tips.2012.03.003_bib0090","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1007\/s10620-006-9644-9","article-title":"PPARbeta\/delta protects against experimental colitis through a ligand-independent mechanism","volume":"52","author":"Hollingshead","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.tips.2012.03.003_bib0095","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/gut.2006.093484","article-title":"PPARgamma as a new therapeutic target in inflammatory bowel diseases","volume":"55","author":"Dubuquoy","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.tips.2012.03.003_bib0100","article-title":"Glucocorticoid sensitivity in inflammatory bowel disease","author":"Sidoroff","year":"2011","journal-title":"Ann. Med."},{"key":"10.1016\/j.tips.2012.03.003_bib0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bbadis.2005.12.006","article-title":"Alterations in intestinal fatty acid metabolism in inflammatory bowel disease","volume":"1762","author":"Heimerl","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2012.03.003_bib0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mce.2011.07.022","article-title":"Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer","volume":"347","author":"Cross","year":"2011","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.tips.2012.03.003_bib0115","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/ibd.21476","article-title":"IRF4 regulates IL-17A promoter activity and controls ROR\u03b3t-dependent Th17 colitis in vivo","volume":"17","author":"Mudter","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.tips.2012.03.003_bib0120","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/ibd.20413","article-title":"Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease","volume":"14","author":"Ahn","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.tips.2012.03.003_bib0125","doi-asserted-by":"crossref","first-page":"G621","DOI":"10.1152\/ajpgi.00274.2010","article-title":"Estrogen receptor-beta signaling modulates epithelial barrier function","volume":"300","author":"Looijer-van Langen","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tips.2012.03.003_bib0130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1476-5381.2010.01129.x","article-title":"Pregnane X receptor- and CYP3A4-humanized mouse models and their applications","volume":"163","author":"Cheng","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.003_bib0135","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1124\/dmd.110.035568","article-title":"Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism","volume":"38","author":"Gao","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tips.2012.03.003_bib0140","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1172\/JCI26283","article-title":"Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation","volume":"116","author":"Zhou","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2012.03.003_bib0145","doi-asserted-by":"crossref","first-page":"e1000594","DOI":"10.1371\/journal.pcbi.1000594","article-title":"Challenges predicting ligand\u2013receptor interactions of promiscuous proteins: the nuclear receptor PXR","volume":"5","author":"Ekins","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.tips.2012.03.003_bib0150","doi-asserted-by":"crossref","first-page":"11572","DOI":"10.1021\/bi901578n","article-title":"The structural basis of pregnane X receptor binding promiscuity","volume":"48","author":"Ngan","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.tips.2012.03.003_bib0155","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1124\/dmd.109.027565","article-title":"Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity","volume":"37","author":"Cheng","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tips.2012.03.003_bib0160","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1046\/j.1432-1033.2002.03207.x","article-title":"Identification of residues in the PXR ligand binding domain critical for species specific and constitutive activation","volume":"269","author":"Ostberg","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.tips.2012.03.003_bib0165","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2217\/14622416.9.11.1695","article-title":"PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics","volume":"9","author":"Zhang","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.tips.2012.03.003_bib0170","doi-asserted-by":"crossref","first-page":"W810","DOI":"10.2214\/AJR.10.5474","article-title":"MR enterography findings of inflammatory bowel disease in pediatric patients","volume":"196","author":"Chalian","year":"2011","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.tips.2012.03.003_bib0175","doi-asserted-by":"crossref","first-page":"G1114","DOI":"10.1152\/ajpgi.00528.2006","article-title":"Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression","volume":"292","author":"Shah","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tips.2012.03.003_bib0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00004836-200204000-00003","article-title":"Intestinal permeation and gastrointestinal disease","volume":"34","author":"DeMeo","year":"2002","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.tips.2012.03.003_bib0185","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/17425250902973695","article-title":"Rifaximin pharmacology and clinical implications","volume":"5","author":"Ojetti","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tips.2012.03.003_bib0190","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.107.121913","article-title":"Rifaximin is a gut-specific human pregnane X receptor activator","volume":"322","author":"Ma","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2012.03.003_bib0195","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejphar.2011.06.058","article-title":"Inhibition of NF-kappaB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells","volume":"668","author":"Mencarelli","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.003_bib0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.110.170225","article-title":"Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation","volume":"335","author":"Cheng","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2012.03.003_bib0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cmet.2007.12.003","article-title":"Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis","volume":"7","author":"Chen","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2012.03.003_bib0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10620-007-9839-8","article-title":"Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS","volume":"53","author":"Yang","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.tips.2012.03.003_bib0215","first-page":"111","article-title":"Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole","volume":"13","author":"Lauritano","year":"2009","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.tips.2012.03.003_bib0220","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10620-009-1111-y","article-title":"Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity","volume":"55","author":"Shafran","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.tips.2012.03.003_bib0225","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MPG.0b013e3181a0d269","article-title":"Use and safety of rifaximin in children with inflammatory bowel disease","volume":"48","author":"Muniyappa","year":"2009","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.tips.2012.03.003_bib0230","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1345\/aph.1P578","article-title":"Probable interaction between warfarin and rifaximin in a patient treated for small intestine bacterial overgrowth","volume":"45","author":"Hoffman","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.tips.2012.03.003_bib0235","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/ajg.2009.270","article-title":"A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy","volume":"104","author":"Trehan","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2012.03.003_bib0240","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2174\/138161209788489177","article-title":"Curcumin has bright prospects for the treatment of inflammatory bowel disease","volume":"15","author":"Hanai","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tips.2012.03.003_bib0245","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.freeradbiomed.2006.09.028","article-title":"Modulation of pregnane X receptor- and electrophile responsive element-mediated gene expression by dietary polyphenolic compounds","volume":"42","author":"Kluth","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tips.2012.03.003_bib0250","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1017\/S0007114508009847","article-title":"The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a\u2212\/\u2212) mice, a model of inflammatory bowel diseases","volume":"101","author":"Nones","year":"2009","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.tips.2012.03.003_bib0255","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1021\/jm200241s","article-title":"Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity","volume":"54","author":"Sepe","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2012.03.003_bib0260","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrgastro.2011.172","article-title":"Optimization of conventional therapy in patients with IBD","volume":"8","author":"Taylor","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tips.2012.03.003_bib0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1067\/mcp.2000.106895","article-title":"Reduction of the inhibitory effect of ketoconazole on budesonide pharmacokinetics by separation of their time of administration","volume":"68","author":"Seidegard","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2012.03.003_bib0270","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0016-5085(00)70210-1","article-title":"High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy","volume":"118","author":"Farrell","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2012.03.003_bib0275","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/138920006775541534","article-title":"Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolyl-penicillin antibiotic flucloxacillin","volume":"7","author":"Huwyler","year":"2006","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.tips.2012.03.003_bib0280","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ajg.2011.72","article-title":"Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis","volume":"106","author":"Khan","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2012.03.003_bib0285","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.gastro.2005.12.008","article-title":"The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease","volume":"130","author":"Dring","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2012.03.003_bib0290","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/ibd.21562","article-title":"Pregnane X receptor (PXR\/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease","volume":"17","author":"Glas","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.tips.2012.03.003_bib0295","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/hmg\/ddi494","article-title":"ABCB1\/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach","volume":"15","author":"Ho","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2012.03.003_bib0300","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/ibd.20252","article-title":"Role of the PXR gene locus in inflammatory bowel diseases","volume":"13","author":"Martinez","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.tips.2012.03.003_bib0305","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0092-8674(00)81698-0","article-title":"Structure of an IkappaBalpha\/NF-kappaB complex","volume":"95","author":"Jacobs","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.tips.2012.03.003_bib0310","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1126\/science.1062677","article-title":"Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway","volume":"293","author":"Senftleben","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tips.2012.03.003_bib0315","doi-asserted-by":"crossref","first-page":"17882","DOI":"10.1074\/jbc.M601302200","article-title":"Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents","volume":"281","author":"Gu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2012.03.003_bib0320","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tox.2007.12.008","article-title":"A mechanism for the anti-fibrogenic effects of the pregnane X receptor (PXR) in the liver: inhibition of NF-kappaB?","volume":"246","author":"Axon","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.tips.2012.03.003_bib0325","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/gut.2007.125468","article-title":"Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease","volume":"56","author":"Henckaerts","year":"2007","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.tips.2012.03.003_bib0330","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.1000092107","article-title":"Epithelial crosstalk at the microbiota\u2013mucosal interface","volume":"108","author":"Wells","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2012.03.003_bib0335","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1348-0421.2010.00267.x","article-title":"The innate immune system in the intestine","volume":"54","author":"Uematsu","year":"2010","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.tips.2012.03.003_bib0340","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1189\/jlb.0411183","article-title":"Nod-like receptors in intestinal homeostasis, inflammation, and cancer","volume":"90","author":"Werts","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.tips.2012.03.003_bib0345","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1124\/dmd.110.037382","article-title":"Differential role of Toll-interleukin 1 receptor domain-containing adaptor protein in Toll-like receptor 2-mediated regulation of gene expression of hepatic cytokines and drug-metabolizing enzymes","volume":"39","author":"Ghose","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tips.2012.03.003_bib0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.abb.2008.10.003","article-title":"Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid","volume":"481","author":"Ghose","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tips.2012.03.003_bib0355","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.3748\/wjg.14.5115","article-title":"New serological biomarkers of inflammatory bowel disease","volume":"14","author":"Li","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tips.2012.03.003_bib0360","doi-asserted-by":"crossref","first-page":"C324","DOI":"10.1152\/ajpcell.00397.2009","article-title":"PGE2 promotes Ca2+-mediated epithelial barrier disruption through EP1 and EP4 receptors in Caco-2 cell monolayers","volume":"299","author":"Rodriguez-Lagunas","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tips.2012.03.003_bib0365","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/jpet.110.171744","article-title":"Pregnane X receptor is SUMOylated to repress the inflammatory response","volume":"335","author":"Hu","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2012.03.003_bib0370","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbrc.2011.02.048","article-title":"Acetylation of pregnane X receptor protein determines selective function independent of ligand activation","volume":"406","author":"Biswas","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2012.03.003_bib0375","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ibd.20328","article-title":"Autoantibodies against ubiquitination factor E4A (UBE4A) are associated with severity of Crohn's disease","volume":"14","author":"Sakiyama","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.tips.2012.03.003_bib0380","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.taap.2008.11.009","article-title":"Arsenite and its metabolites, MMA(III) and DMA(III), modify CYP3A4, PXR and RXR alpha expression in the small intestine of CYP3A4 transgenic mice","volume":"239","author":"Medina-Diaz","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tips.2012.03.003_bib0385","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1124\/jpet.109.164954","article-title":"Novel anti-inflammatory action of 5-aminoimidazole-4-carboxamide ribonucleoside with protective effect in dextran sulfate sodium-induced acute and chronic colitis","volume":"333","author":"Bai","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2012.03.003_bib0390","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/jpet.109.157180","article-title":"A systematic analysis of predicted phosphorylation sites within the human pregnane X receptor protein","volume":"331","author":"Lichti-Kaiser","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2012.03.003_bib0395","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1124\/dmd.108.024695","article-title":"A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane X receptor","volume":"37","author":"Pondugula","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tips.2012.03.003_bib0400","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2011.02.011","article-title":"Post-translational modification of pregnane X receptor","volume":"64","author":"Staudinger","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tips.2012.03.003_bib0405","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2174\/138161209787846784","article-title":"The gut mucosa as a site for induction of regulatory T-cells","volume":"15","author":"Mizrahi","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tips.2012.03.003_bib0410","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.4049\/jimmunol.181.7.4709","article-title":"Goblet cell-derived resistin-like molecule beta augments CD4+ T cell production of IFN-gamma and infection-induced intestinal inflammation","volume":"181","author":"Nair","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2012.03.003_bib0415","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.molimm.2006.04.021","article-title":"Nuclear receptors in human immune cells: expression and correlations","volume":"44","author":"Schote","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.tips.2012.03.003_bib0420","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/toxsci\/kfl120","article-title":"Photochemotherapeutic agent 8-methoxypsoralen induces cytochrome P450 3A4 and carboxylesterase HCE2: evidence on an involvement of the pregnane X receptor","volume":"95","author":"Yang","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tips.2012.03.003_bib0425","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jsbmb.2010.04.012","article-title":"The PXR is a drug target for chronic inflammatory liver disease","volume":"120","author":"Wallace","year":"2010","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.tips.2012.03.003_bib0430","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.4049\/jimmunol.0902151","article-title":"Modulation of T lymphocyte function by the pregnane X receptor","volume":"184","author":"Dubrac","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2012.03.003_bib0435","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/13543780902780175","article-title":"Review of rifaximin as treatment for SIBO and IBS","volume":"18","author":"Pimentel","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.tips.2012.03.003_bib0440","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1172\/JCI41514","article-title":"Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice","volume":"121","author":"Wang","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2012.03.003_bib0445","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/sj.bjc.6605677","article-title":"Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells","volume":"102","author":"Ouyang","year":"2010","journal-title":"Br. J. Cancer"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614712000351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614712000351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T05:24:54Z","timestamp":1542950694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614712000351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0165614712000351"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2012.03.003","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}